214 related articles for article (PubMed ID: 21927560)
1. Pre-operative prediction of advanced prostatic cancer using clinical decision support systems: accuracy comparison between support vector machine and artificial neural network.
Kim SY; Moon SK; Jung DC; Hwang SI; Sung CK; Cho JY; Kim SH; Lee J; Lee HJ
Korean J Radiol; 2011; 12(5):588-94. PubMed ID: 21927560
[TBL] [Abstract][Full Text] [Related]
2. Image-based clinical decision support for transrectal ultrasound in the diagnosis of prostate cancer: comparison of multiple logistic regression, artificial neural network, and support vector machine.
Lee HJ; Hwang SI; Han SM; Park SH; Kim SH; Cho JY; Seong CG; Choe G
Eur Radiol; 2010 Jun; 20(6):1476-84. PubMed ID: 20016902
[TBL] [Abstract][Full Text] [Related]
3. Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine.
Ecke TH; Bartel P; Hallmann S; Koch S; Ruttloff J; Cammann H; Lein M; Schrader M; Miller K; Stephan C
Urol Oncol; 2012; 30(2):139-44. PubMed ID: 20363164
[TBL] [Abstract][Full Text] [Related]
4. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
[TBL] [Abstract][Full Text] [Related]
5. An artificial neural network to predict the outcome of repeat prostate biopsies.
Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
[TBL] [Abstract][Full Text] [Related]
6. Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer.
Balaji KC; Fair WR; Feleppa EJ; Porter CR; Tsai H; Liu T; Kalisz A; Urban S; Gillespie J
J Urol; 2002 Dec; 168(6):2422-5. PubMed ID: 12441931
[TBL] [Abstract][Full Text] [Related]
7. Role of transrectal ultrasonography in the prediction of prostate cancer: artificial neural network analysis.
Lee HJ; Kim KG; Lee SE; Byun SS; Hwang SI; Jung SI; Hong SK; Kim SH
J Ultrasound Med; 2006 Jul; 25(7):815-21; quiz 822-4. PubMed ID: 16798891
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.
Stephan C; Xu C; Finne P; Cammann H; Meyer HA; Lein M; Jung K; Stenman UH
Urology; 2007 Sep; 70(3):596-601. PubMed ID: 17688922
[TBL] [Abstract][Full Text] [Related]
9. Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer.
Zhang M; Liu Y; Yao J; Wang K; Tu J; Hu Z; Jin Y; Du Y; Sun X; Chen L; Wang Z
Front Endocrinol (Lausanne); 2023; 14():1137322. PubMed ID: 36967794
[TBL] [Abstract][Full Text] [Related]
10. Novel artificial neural network for early detection of prostate cancer.
Djavan B; Remzi M; Zlotta A; Seitz C; Snow P; Marberger M
J Clin Oncol; 2002 Feb; 20(4):921-9. PubMed ID: 11844812
[TBL] [Abstract][Full Text] [Related]
11. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
12. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.
Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF
Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315
[TBL] [Abstract][Full Text] [Related]
13. The value of an artificial neural network in the decision-making for prostate biopsies.
Meijer RP; Gemen EF; van Onna IE; van der Linden JC; Beerlage HP; Kusters GC
World J Urol; 2009 Oct; 27(5):593-8. PubMed ID: 19562346
[TBL] [Abstract][Full Text] [Related]
14. When to biopsy and when to stop biopsying.
Djavan B; Remzi M; Marberger M
Urol Clin North Am; 2003 May; 30(2):253-62, viii. PubMed ID: 12735502
[TBL] [Abstract][Full Text] [Related]
15. Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study.
Porter CR; O'Donnell C; Crawford ED; Gamito EJ; Sentizimary B; De Rosalia A; Tewari A
Urology; 2002 Nov; 60(5):831-5. PubMed ID: 12429310
[TBL] [Abstract][Full Text] [Related]
16. Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing.
Park JY; Yoon S; Park MS; Cho DY; Park HS; Moon du G; Yoon DK
J Korean Med Sci; 2011 Jan; 26(1):85-91. PubMed ID: 21218035
[TBL] [Abstract][Full Text] [Related]
17. The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years.
Boegemann M; Stephan C; Cammann H; Vincendeau S; Houlgatte A; Jung K; Blanchet JS; Semjonow A
BJU Int; 2016 Jan; 117(1):72-9. PubMed ID: 25818705
[TBL] [Abstract][Full Text] [Related]
18. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
20. PSA density improves prediction of prostate cancer.
Verma A; St Onge J; Dhillon K; Chorneyko A
Can J Urol; 2014 Jun; 21(3):7312-21. PubMed ID: 24978363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
